Turning Evidence into Access
Explore What We Offer-
200 +
Submissions to Payers in the last 5 years
-
200 +
Publications & Posters
-
75 +
Therapeutic Areas
-
50 +
Clients
-
60 +
Real-world evidence & PROxy studies
Who We Are
One Partner. From Evidence Generation to Patient Access.
For more than 20 years, PeriPharm has partnered with life sciences companies to navigate the complexities of the Canadian market access landscape — from generating the evidence that demonstrates value to developing the strategies that help bring innovative therapies to patients.
Our integrated, end-to-end approach brings together deep expertise in HEOR, evidence generation, and market access strategy, combined with a strong understanding of the Canadian payer environment. Through tailored, evidence-based solutions, we help demonstrate value, inform decision-making, and optimize access to therapies that improve patient outcomes.
We believe the best results come from strong partnerships. Our approach is built on collaboration, agility, transparency, and a genuine commitment to our clients’ success.
Leadership Driven by a Shared Vision.
Founded in 2003 by Jean Lachaine, Ph.D., PeriPharm was built with a clear mission: to leverage deep expertise in pharmacoeconomics, health technology assessment, and the pharmaceutical industry to help clients successfully bring innovative therapies to patients. In 2008, Catherine Beauchemin, Ph.D. brought to the company a strong commitment to expanding PeriPharm’s capabilities and service offerings. Together, they have built a multidisciplinary team of highly specialized professionals and cultivated long-standing partnerships with clients.
Jean and Catherine’s complementary expertise and shared entrepreneurial vision have shaped PeriPharm into a leader in Canadian market access and drug reimbursement. They have fostered sustainable growth while remaining grounded in the values that define the organization: scientific rigor, innovation, expertise, integrity, and collaboration. Their commitment to these values extends to their relationships with clients and their support of the professional development of their team, helping build trusted partnerships that create lasting value.
Why Choose Us?
Our expertise extends well beyond preparing Canadian payer submissions and generating evidence. We understand what matters to Canadian payers and how to generate and translate the right evidence into compelling market access strategies. We go beyond traditional consulting by working as an extension of our clients’ teams, collaborating closely throughout each engagement to bring the right expertise and strategic perspective.
What Distinguishes Us
- End-to-end partnership
- Uncompromising scientific rigor
- Personalized, collaborative approach
- Direct access to experts
- Integrated capabilities
- Bilingual team
- Deep expertise in evidence generation
- Strategic insights beyond analysis
Our Services
-
Submissions to Payers
Preparing all components required by Canadian payers to support a strong reimbursement submission.
-
Health Economics
Developing rigorous economic models, including cost-utility analyses, cost-minimization analyses, budget impact analyses, and more.
-
Real-World Evidence
Generating robust, real-world insights to support decision-making and demonstrate value.
-
Evidence Synthesis
Integrating evidence from the literature to assess and compare treatment efficacy and safety.
-
Strategic Consulting
Developing tailored strategies to optimize market access in Canada.
The PROxy Network is a unique initiative developed by PeriPharm to generate patient-reported outcomes (PROs) and capture meaningful patient input. Built on the belief that patients should be at the heart of healthcare decision-making, this web-based platform translates patient perspectives and experiences into valuable evidence to inform healthcare decisions.